Thus, TNF-α and IL-6 are major proinflammatory cytokines that are pivotally involved in the pathogenesis of RA, and TNF-α and IL-6 inhibitors are used clinically to treat RA [18,19,20,21]. The gene discussed is TNF; the disease is rheumatoid arthritis.